Ricolinostat (ACY-1215)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ricolinostat (ACY-1215), covering 2025-03-04 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL [Phase 1]